further revealed that IL1RAP mediates the interaction between tumor cells and M2-type macrophages following PD-1 treatment, which subsequently alters the neutrophil-to-lymphocyte ratio, contributing to an unfavorable prognosis for patients (30). Here, IL1RAP is linked to neoplasm.